TF
ABBV icon

Talbot Financial’s AbbVie ABBV Stock Holding History

Talbot Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.1M Buy
131,696
+4,590
+4% +$988K 2.44% 11
2026
Q1 		$27.6M Buy
127,106
+5,371
+4% +$1.19M 2.32% 12
2025
Q4 		$27.8M Buy
121,735
+851
+0.7% +$194K 2.29% 11
2025
Q3 		$28M Buy
120,884
+4,537
+4% +$924K 2.37% 9
2025
Q2 		$21.6M Buy
116,347
+22,115
+23% +$4.11M 2.04% 12
2025
Q1 		$19.7M Sell
94,232
-2,277
-2% -$443K 2.47% 8
2024
Q4 		$17.1M Buy
96,509
+4,503
+5% +$828K 2.04% 12
2024
Q3 		$18.2M Buy
92,006
+1,344
+1% +$251K 2.21% 11
2024
Q2 		$15.6M Buy
90,662
+1,168
+1% +$193K 2.01% 14
2024
Q1 		$16.3M Buy
89,494
+954
+1% +$164K 2.18% 13
2023
Q4 		$13.7M Buy
88,540
+4,661
+6% +$680K 2.06% 14
2023
Q3 		$12.5M Buy
83,879
+1,989
+2% +$292K 2.18% 11
2023
Q2 		$11M Buy
81,890
+589
+0.7% +$86.4K 1.88% 14
2023
Q1 		$13M Sell
81,301
-15,797
-16% -$2.42M 2.41% 9
2022
Q4 		$15.7M Buy
+97,098
New +$14.9M 3.23% 4

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Talbot Financial's ABBV Position: Q2 2026 in Review

Talbot Financial increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $988K and bringing the position to 131,696 shares worth $33.1M. The position accounts for 2.44% of the portfolio, ranked #11.

Talbot Financial first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Talbot Financial held 131,696 shares of AbbVie worth $33.1M as of Q2 2026.
  • Talbot Financial bought 4,590 AbbVie shares in Q2 2026, an estimated $988K.
  • AbbVie made up 2.44% of Talbot Financial's portfolio in Q2 2026, its #11 holding.
  • Talbot Financial first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Talbot Financial's 13F filing for Q2 2026, filed 14 Jul 2026.